These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 5778831

  • 1. Response of childhood rhabdomyosarcoma to combination chemotherapy.
    Pratt CB.
    J Pediatr; 1969 May; 74(5):791-4. PubMed ID: 5778831
    [No Abstract] [Full Text] [Related]

  • 2. Combination chemotherapy for embryonal rhabdomyosarcoma.
    Wilbur JR.
    Cancer Chemother Rep; 1974 May; 58(2):281-4. PubMed ID: 4830502
    [No Abstract] [Full Text] [Related]

  • 3. Combined chemotherapy in childhood rhabdomyosarcoma.
    Pullen DJ, Dyment PG, Hymphrey GB, Lane DM, Ragab AH.
    Cancer Chemother Rep; 1975 May; 59(2 Pt 1):359-65. PubMed ID: 50123
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Combined treatment of rhabdomyosarcoma in children].
    Armata J, Cyklis R, Legutko L, Małek T, Sitarska B, Turkiewicz A.
    Pol Tyg Lek; 1981 May 11; 36(19):675-7. PubMed ID: 6167974
    [No Abstract] [Full Text] [Related]

  • 9. Extended combination therapy of childhood rhabdomyosarcoma.
    Holton CP, Chapman KE, Lackey RW, Hatch EI, Baum ES, Favara BE.
    Cancer; 1973 Dec 11; 32(6):1310-6. PubMed ID: 4202189
    [No Abstract] [Full Text] [Related]

  • 10. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Walterhouse DO, Pappo AS, Meza JL, Breneman JC, Hayes-Jordan A, Parham DM, Cripe TP, Anderson JR, Meyer WH, Hawkins DS.
    Cancer; 2017 Jun 15; 123(12):2368-2375. PubMed ID: 28211936
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.
    Kojima Y, Hashimoto K, Ando M, Yonemori K, Yamamoto H, Kodaira M, Yunokawa M, Shimizu C, Tamura K, Hosono A, Makimoto A, Fujiwara Y.
    Cancer Chemother Pharmacol; 2012 Sep 15; 70(3):391-7. PubMed ID: 22806306
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A case of rhabdomyosarcoma of the prostate in children].
    Nagata Y, Hoshino H, Kinoshita H, Kawamura N, Suzuki K.
    Hinyokika Kiyo; 1985 Feb 15; 31(2):319-26. PubMed ID: 3893070
    [Abstract] [Full Text] [Related]

  • 19. [New combination chemotherapy in refractory rhabdomyosarcoma of the prostate: a case report and review of the literature].
    Takeuchi T, Komeda H, Oguchi K, Ishihara S, Iwata H, Kanematsu M, Kuriyama M, Ban Y, Tanaka T.
    Hinyokika Kiyo; 1987 Nov 15; 33(11):1899-905. PubMed ID: 2451411
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.